Home » Stocks » APDN

Applied DNA Sciences, Inc. (APDN)

Stock Price: $7.34 USD -1.44 (-16.40%)
Updated Mar 4, 2021 1:13 PM EST - Market open
Market Cap 66.51M
Revenue (ttm) 2.91M
Net Income (ttm) -15.17M
Shares Out 5.46M
EPS (ttm) -3.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 4
Last Price $7.34
Previous Close $8.78
Change ($) -1.44
Change (%) -16.40%
Day's Open 8.73
Day's Range 7.25 - 8.73
Day's Volume 423,806
52-Week Range 2.52 - 16.39

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 2 days ago

STONY BROOK, N.Y. & ROME--(BUSINESS WIRE)---- $APDN #COVID19--If the veterinary vaccine candidate demonstrates effectiveness, the two companies intend to apply to USDA to enable commercial vet...

Business Wire - 1 week ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #DSCSA--Newly granted patent has applicability in the DNA tagging of pharmaceutical, nutraceutical and personal care excipients.

Business Wire - 1 week ago

STONY BROOK, N.Y. & NEW YORK--(BUSINESS WIRE)---- $APDN #COVID19--NYC-based LIM College joins other education institutions relying on Applied DNA's safeCircle service to ensure a safe learning...

Zacks Investment Research - 2 weeks ago

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -12.73% and 15.43%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for ...

Business Wire - 2 weeks ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Reports First Fiscal Quarter 2021 Revenues at Upper End of Guided Range

Business Wire - 3 weeks ago

STONY BROOK, N.Y. & PARSONS, Kansas--(BUSINESS WIRE)---- $APDN #COVID19--Linea(TM) COVID-19 Assay Kit utilized in genomic surveillance mode detects first instance of SARS-CoV-2 B.1.1.7 (UK) va...

Business Wire - 3 weeks ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) announced today that it will report fiscal 2021 first quarter financial results after market cl...

Business Wire - 1 month ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--"Our veterinary vaccine program is a cost- and time-efficient path to commercializing our COVID-19 vaccine development work."

Zacks Investment Research - 1 month ago

Applied DNA Sciences (APDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 1 month ago

TORONTO--(BUSINESS WIRE)--TruTrace Technologies, Inc. (CSE: TTT) (“TruTrace” or the “Company”), developer of a fully-integrated blockchain platform for the legal cannabis, food and pharmaceuti...

Business Wire - 1 month ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced th...

Business Wire - 1 month ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today ann...

Business Wire - 1 month ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today ann...

Benzinga - 1 month ago

Applied DNA Sciences (NASDAQ: APDN) shares are trading higher on reports the U.K. COVID strain could become the dominant strain in the U.S. The FDA last week reported the company's test is sen...

Business Wire - 1 month ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ:APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today anno...

Business Wire - 1 month ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced...

Business Wire - 1 month ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today th...

Benzinga - 1 month ago

Applied DNA Sciences (NASDAQ: APDN) shares are trading higher after the U.S. Food and Drug Administration published communication that identifies the company's Linea COVID-19 Assay Kit as one ...

Business Wire - 1 month ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced...

Business Wire - 1 month ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced...

Business Wire - 2 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufac...

Business Wire - 2 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufac...

Seeking Alpha - 2 months ago

Seeking Alpha Transcripts | Healthcare Applied DNA Sciences, Inc. (APDN) CEO James Hayward on Q4 2020 Results - Earnings Call Transcript Dec. 17, 2020 10:09 PM ET | | About: Applied DNA Scienc...

Zacks Investment Research - 2 months ago

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -38.98% and -55.14%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead fo...

Benzinga - 2 months ago

Shares of Applied DNA Sciences (NASDAQ:APDN) fell 21.15% after the company reported Q4 results. Quarterly Results Earnings per share rose 43.06% year over year to ($0.82), which missed the est...

Business Wire - 2 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufac...

Business Wire - 2 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufac...

Business Wire - 2 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufac...

Business Wire - 2 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufac...

Business Wire - 2 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, t...

Business Wire - 3 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufac...

Business Wire - 3 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufac...

Business Wire - 3 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, a...

Business Wire - 3 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufact...

Business Wire - 3 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufac...

Business Wire - 3 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc., (NASDAQ: APDN) (“Applied DNA” or the "Company") a leader in Polymerase Chain Reaction (PCR)-based DNA manufac...

Business Wire - 4 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #AAV--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturi...

Business Wire - 4 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufac...

Business Wire - 4 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufac...

Business Wire - 4 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #biotech--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufac...

Business Wire - 5 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufac...

Business Wire - 5 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing th...

Business Wire - 5 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc.

Business Wire - 6 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc.

Business Wire - 6 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc.

Business Wire - 6 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc.

Business Wire - 6 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc.

Seeking Alpha - 6 months ago

Applied DNA Sciences, Inc. (APDN) CEO James Hayward on Q3 2020 Results - Earnings Call Transcript

Business Wire - 6 months ago

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc.

Investors Business Daily - 6 months ago

Applied Dna Sciences shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. The post Stocks Showing Market Leadership: Applied Dna Sciences Earns 93 RS Rati...

About APDN

Applied DNA Sciences develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications and can be used to fortify br... [Read more...]

Industry
Security & Protection Services
Founded
1983
CEO
James Hayward
Employees
59
Stock Exchange
NASDAQ
Ticker Symbol
APDN
Full Company Profile

Financial Performance

In 2020, APDN's revenue was $1.93 million, a decrease of -64.16% compared to the previous year's $5.39 million. Losses were -$13.03 million, 51.1% more than in 2019.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for APDN stock is "Buy." The 12-month stock price forecast is 18.67, which is an increase of 154.36% from the latest price.

Price Target
$18.67
(154.36% upside)
Analyst Consensus: Buy